Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»BioTech»OIC Medicines Authorities committed to cooperating toward Safe, Efficacious and Standardized Medicines and Vaccine Self-Reliance
    BioTech

    OIC Medicines Authorities committed to cooperating toward Safe, Efficacious and Standardized Medicines and Vaccine Self-Reliance

    Marie JonesBy Marie JonesNovember 25, 2018Updated:November 26, 2018No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    – First Meeting of OIC NMRAs concludes in the Jakarta Declaration

    JAKARTA – (ACN Newswire) – The heads of National Medicines Authorities (NMRA) from the Organization of Islamic Cooperation (OIC) announced the Jakarta Declaration during their first meeting, held here November 21-22. The declaration contains, among others, efforts to harmonize standards of vaccine and self-reliance in medicines, and intensify cooperation between OIC NMRA members.

    The declaration emphasizes enhanced health levels and the well being of member communities with self-reliance on the production and assured access to safe and efficacious medicines and vaccine, and increased production capacity through innovation and the development of domestic medicine and vaccine industries.

    “The Jakarta Declaration is the commitment from OIC NMRAs to work together, towards the Action Plan and its various programs fostering self-reliance. With the diversity of conditions in the OIC, it is our duty to help each other in improving the capacity of regulators and the pharma industries to strengthen aspects of access to safe, quality medicines and vaccines,” said Penny K. Lukito, Head of Indonesia’s National Agency of Drug and Food Control (BPOM).

    “We are thankful to all participants in the meeting, and the collaboration between OIC Member States. The Jakarta Declaration and Action Plan to promote collaboration are proof of unity and solidarity between the OIC Member State NMRAs towards self-sustaining health developments,” she said.

    The meeting addressed various issues surrounding medicines and vaccines, including regulatory status and role of regulatory authorities in ensuring drug quality and availability, efforts at the harmonization of medicine and vaccine standards towards achieving self-reliance, experiences from members regarding halal medicines and vaccines, and NMRA role in the control of counterfeit medicines and vaccines.

    The members agreed to improve cooperation between NMRAs through greater exchange of information and increasing the capacity of human resources to strengthen detection, prevention, and response towards counterfeit and substandard medicines and vaccines, adopting an ‘OIC Action Plan to promote collaboration among OIC NMRAs for self-reliance in Medicines and Vaccines’.

    The membership was also in support of a BPOM suggestion to form a steering committee and working groups which would further discuss the central issues of halal medicine and standards for harmonization.

    Then after 2 days of discussions, passage of the Jakarta Declaration, which noted with concern that many countries, including OIC Member States, have insufficient or no pharma manufacturing capabilities, or a local industry which produces but a fraction of demand, so heavy reliance on imports and medicinal aid.

    Main OIC Meeting 2018 website : https://www.pom.go.id/nmra-oicmeeting2018/
    Side NMRA OIC Events website : https://sideevents.nmra-oic1stmeeting.com/
    Indonesian BPOM English website : https://www.pom.go.id/new/home/en/

    NMRA OIC First Meeting 2018
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleCITIC Telecom CPC wins Industry Award for Best Cloud Service Provider
    Next Article TIME Interconnect Technology Limited Announces 2018 Interim Results

    Related Posts

    Everest Medicines Secures Exclusive License for Sumecigrel in Asia-Pacific, Expanding Its Cardiovascular Product Portfolio

    June 9, 2026

    Hua Medicine Advances Glucose Homeostasis Platform at ADA 2026, Showcasing Dorzagliatin’s Potential Across Metabolic Disease

    June 9, 2026

    ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801’s Renoprotective Potential in Oral Presentation

    June 5, 2026
    Add A Comment

    Comments are closed.

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.